Mutations in epigenetic regulators (CREBBP, EP300, MLL, MLL2 and EZH2) and in the NOTCH family (mostly NOTCH1) are also present in SCLC, with the latter having a main impact on neuroendocrine differentiation and expansion [9, 17]. Here, EZH2 is linked to small cell lung carcinoma.